Showing 4561-4570 of 6947 results for "".
- Metabolomic Signature Predictive of Ocular Side Effects in Dupilumab-Treated AD: Studyhttps://practicaldermatology.com/news/metabolomic-signature-may-predict-ocular-side-effects-in-dupilumab-treated-atopic-dermatitis-study/2474199/New research suggests baseline metabolic differences may help predict which patients with atopic dermatitis (AD) are most likely to develop ocular complications from dupilumab. In findings published in
- Pelthos Therapeutics and Channel Therapeutics to Mergehttps://practicaldermatology.com/news/pelthos-therapeutics-and-channel-therapeutics-to-merge/2474190/Ligand Pharmaceuticals has announced a definitive merger agreement that will combine its wholly owned subsidiary Pelthos Therapeutics with Channel Therapeutics Corporation, forming a publicly traded company under the name Pelthos Therapeutics Inc. The deal is suppo
- Melanoma Risk Model Validated in Global Studyhttps://practicaldermatology.com/news/international-study-strengthens-confidence-in-sentinel-node-prediction-tool/2474126/The Melanoma Institute Australia (MIA) sentinel node (SN) metastasis risk calculator has been validated in a large, multinational cohort, reinforcing its applicability across diverse populations and clinical settings. The MIA
- CAB Gel Reduces Lesions and Preserves Skin Tone in Skin of Colorhttps://practicaldermatology.com/news/cab-gel-reduces-lesions-and-preserves-skin-tone-in-skin-of-color/2474010/A post hoc analysis of pooled Phase 2 and Phase 3 clinical trial data suggests that clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is effective and well tolerated for the treatment of moderate to severe acne in Black patients.
- Study Links Psoriasis Gene Regulation to Spatial Genome Changeshttps://practicaldermatology.com/news/study-links-psoriasis-gene-regulation-to-spatial-genome-changes/2474007/Results from a new study in the Journal of Investigative Dermatology showed how changes in the 3D chromatin architecture of CD4+ T cells contribute to immune dysregulation in psoriasis. "In this study, the 3D genomic
- Study: Dermabrasion Trials Rarely Report Race or Skin Typehttps://practicaldermatology.com/news/study-dermabrasion-trials-rarely-report-race-or-skin-type/2474005/Most clinical trials studying dermabrasion have failed to report racial or skin-type demographics, according to a new systematic review. "Clinical trials that are racially homogenous or do not report race limit the generalizab
- Researchers Identify Novel IL-17A-Linked Psoriasis Gene and Therapeutic Targethttps://practicaldermatology.com/news/plek-identified-as-novel-il-17a-linked-psoriasis-gene-and-therapeutic-target/2473942/Machine learning and in vivo experimentation have identified
- Report: Seborrheic Dermatitis Market Poised for Expansion through 2032https://practicaldermatology.com/news/report-seborrheic-dermatitis-market-poised-for-expansion-through-2032/2473856/The seborrheic dermatitis market has been projected to grow through 2032, according to a new report from Delveinsight. The expansion in market size coincides with the CAGR study, according to a press release. The report notes the recent approval of roflumilast foam 0.3% (ZORYVE, Arcutis) f
- Analysis: Proximity to Tanning Facilities Correlates with Increased Melanoma Incidence in New Englandhttps://practicaldermatology.com/news/analysis-proximity-to-tanning-facilities-correlates-with-increased-melanoma-incidence-in-new-england/2473824/Results from a new analysis suggest a correlation between proximity to tanning facilities and higher melanoma inc
- Registration Opens for the Tell-All Tribune and Genesis Meetingshttps://practicaldermatology.com/news/Registration-Opens-Tell-All-Tribune-Genesis-Meetings/2471850/Registration is open for two Modern Aesthetics meetings that were overwhelmingly popular in 2024 and now will be held on the same weekend, June 20-21, at the W Hotel in Fort Lauderdale, Florida. The Tell-All Tribune: An Aesthetic Think Tank, which was an invitation-only event in its inaugu